21 C.F.R. §1301.74 - Other security controls for non-practitioners; narcotic treatment programs and compounders for narcotic treatment programs; mobile narcotic treatment programs
| Cite as | 21 C.F.R. §1301.74 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
50 cases
-
City of S.F. v. Purdue Pharma L.P., Case No. 3:18-cv-07591-CRB
...and distributors—to "design and operate a system to disclose to the registrant suspicious orders of controlled substances." 21 C.F.R. 1301.74(b). The MDL court concluded that these regulations impose duties on manufacturers and distributors to identify, report, and refrain from shipping sus......
-
Walmart Inc. v. U.S. Dep't of Justice, CIVIL NO. 4:20-CV-817-SDJ
...suspicious orders of controlled substances" and to notify DEA of such "suspicious orders" when discovered by the registrant. 21 C.F.R. § 1301.74(b). The regulation defines "suspicious orders" to include "orders of unusual size, orders deviating substantially from a normal pattern, and order......
-
Rochester Drug Co-Operative, Inc. v. Hiscox Ins. Co., 6:20-CV-06025 EAW
...substances made by its pharmacy customers that should have been reported as suspicious pursuant to the criteria set forth in 21 C.F.R. § 1301.74(b) and the guidance contained in the DEA Letters.(Dkt. 15 at 309).Plaintiff does not conclusively admit to deliberately committing a crime or deli......
-
Walmart Inc. v. U.S. Dep't of Justice, Civil No. 4:20-CV-817-SDJ
...suspicious orders of controlled substances" and to notify DEA of such "suspicious orders" when discovered by the registrant. 21 C.F.R. § 1301.74(b). The regulation defines "suspicious orders" to include "orders of unusual size, orders deviating substantially from a normal pattern, and order......
Request a trial to view additional results
9 firm's commentaries
-
Coronavirus: Relief for Behavioral Health Providers in Agency Waivers, Guidance
...to Patients On March 16, 2020, the Drug Enforcement Administration (DEA) granted a waiver request by SAMHSA from the requirements in 21 C.F.R. § 1301.74(i) during the public health emergency declared by the Secretary of Health and Human Services (HHS) on January 31, 2020 to allow DEA-regist......
-
First of Its Kind: Drug Wholesaler Accepts DPA and Two Executives Face Criminal Charges in SDNY For Illegal Distribution of Opioids
...other than legitimate medical, scientific, and industrial channels” under 21 USC § 823(b)(1) and reporting suspicious orders under 21 CFR § 1301.74(b). The criminal pleadings include allegations that: For five years (2012-2017), RDC allegedly “took steps to conceal its illicit distribution ......
-
First Of Its Kind: Drug Wholesaler Accepts DPA And Two Executives Face Criminal Charges In SDNY For Illegal Distribution Of Opioids
...other than legitimate medical, scientific, and industrial channels" under 21 USC § 823(b)(1) and reporting suspicious orders under 21 CFR § 1301.74(b). The criminal pleadings include allegations For five years (2012-2017), RDC allegedly "took steps to conceal its illicit distribution of con......
-
First of Its Kind: Drug Wholesaler Accepts DPA and Two Executives Face Criminal Charges in SDNY For Illegal Distribution of Opioids
...other than legitimate medical, scientific, and industrial channels” under 21 USC § 823(b)(1) and reporting suspicious orders under 21 CFR § 1301.74(b). The criminal pleadings include allegations For five years (2012-2017), RDC allegedly “took steps to conceal its illicit distribution of con......
Request a trial to view additional results
2 provisions
-
Act 443, SB 39 – HEALTH CARE: Provides for the Louisiana Board of Drug and Device Distributors
...in Louisiana and excessive controlled substance purchase reports for all controlled substance registrants in Louisiana required by 21 CFR 1301.74(b) as requested by the Louisiana Board of Pharmacy. Notwithstanding any other law to the contrary, these reports shall be confidential and shall ......
-
P.A. 19-0191, HB 7159 – AN ACT ADDRESSING OPIOID USE
...Division a copy of any suspicious [activity reporting] orders submitted to the federal Drug Enforcement Administration pursuant to 21 CFR 1301.74.(2) Each registered manufacturer or wholesaler of drugs that, based on concerns of potential diversion, ceases or declines distribution of any sc......